Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem

INTRODUCTION: At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, controversial data were reported concerning angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) that induced a number of physicians to stop using them in patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Cugno, Massimo, Gualtierotti, Roberta, Casazza, Giovanni, Tafuri, Francesco, Ghigliazza, Gabriele, Torri, Adriana, Costantino, Giorgio, Montano, Nicola, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012518/
https://www.ncbi.nlm.nih.gov/pubmed/33792889
http://dx.doi.org/10.1007/s12325-021-01704-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012518/
https://www.ncbi.nlm.nih.gov/pubmed/33792889
http://dx.doi.org/10.1007/s12325-021-01704-y

Ejemplares similares